Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThese changes update the Publications section to say publications are automatically filled from PubMed, and update the page revision to v3.3.2. They do not affect the study data, eligibility criteria, or locations.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding status notice at the top of the page was removed. No study details, eligibility criteria, or results were changed.SummaryDifference0.4%

- Check35 days agoChange DetectedThe page now displays branding for the Moffitt Cancer Center and Research Institute and includes a Helpful Links section.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows updated study record dates, including the last update and results posting dates. Core study details such as completion status and locations appear current.SummaryDifference0.4%

- Check71 days agoChange Detected- Added a government funding lapse notice and operating status details for the NIH Clinical Center, plus a link to relevant official sites. - Upgraded version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check78 days agoChange DetectedThe page updates its metadata to reflect a newer version (v3.1.0) and more recent dates (September 2025), while removing older metadata (v3.0.2 and May 2025 dates).SummaryDifference0.7%

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.